Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Blood pressure meds may do more harm than good for frail seniors

NCT ID NCT05047731

Disease control Sponsor: University of Alberta Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether it is safe to reduce blood pressure medication in frail older adults living in long-term care. Researchers enrolled 522 residents with low blood pressure and tested a gradual medication reduction plan. The goal was to see if this approach could lower the risk of falls, confusion, and other harms without increasing heart problems or death.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

522 people

The number who actually took part.

Started

Sep 2021

Finished

Nov 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

70 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * ≥2 diagnoses (dx) of hypertension from either a community practitioner or/and from a hospital admission. * On ≥1 oral antihypertensive medication (requires a dispensation in the preceeding 15 days). * Average recorded systolic BP of \<135 mmHg. Exclusion Criteria: * ≥2 community dx of congestive heart failure, ≥1 dx of in hospital congestive heart failure, ≥1 dx of emergency visit of congestive heart failure, dx of congestive heart failure in RAI-MDS 2.0, or prescription of furosemide in the last 15 days. * The resident's only antihypertensive prescribed is a beta blocker. * The resident's only antihypertensive prescribed is a calcium channel blocker and the resident has ≥1 health system encounters with a diagnosis of angina. * The resident's only antihypertensive prescribed is an alpha blocker. * Admitted to the hospital at the time of randomization; or opted out of the trial by the resident, their family, their physician, or the facility.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Frailty are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Frailty hypertensive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Frailty Hypertension

Contacts and locations

Locations

  • Multiple long-term care facilities

    Multiple Locations, Alberta, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.